🇨🇦 BNT162b2 (Omi XBB.1.5)/RIV in Canada

BNT162b2 (Omi XBB.1.5)/RIV (bnt162b2-omi-xbb-1-5-riv) regulatory status in Canada.

Marketing authorisation

BNT162b2 (Omi XBB.1.5)/RIV in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Canada

Frequently asked questions

Is BNT162b2 (Omi XBB.1.5)/RIV approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for BNT162b2 (Omi XBB.1.5)/RIV in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.